Literature DB >> 10203536

Invasive aspergillosis caused by Aspergillus ustus: case report and review.

P E Verweij1, M F van den Bergh, P M Rath, B E de Pauw, A Voss, J F Meis.   

Abstract

A case of invasive pulmonary aspergillosis in an allogeneic bone marrow transplant recipient caused by Aspergillus ustus is presented. A. ustus was also recovered from the hospital environment, which may indicate that the infection was nosocomially acquired. A literature review revealed seven cases of invasive infections caused by A. ustus, and three of these were primarily cutaneous infections. In vitro susceptibility testing of 12 A. ustus isolates showed that amphotericin B and terbinafine had fungicidal activity and that itraconazole and voriconazole had fungistatic activity.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10203536      PMCID： PMC84848     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

Review 1.  Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections.

Authors:  P E Verweij; D Poulain; T Obayashi; T F Patterson; D W Denning; J Ponton
Journal:  Med Mycol       Date:  1998       Impact factor: 4.076

2.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors.

Authors:  S J Mitchell; J Gray; M E Morgan; M D Hocking; G M Durbin
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

3.  Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.

Authors:  C M Swanink; J F Meis; A J Rijs; J P Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Invasive aspergillosis presenting as pericarditis and cardiac tamponade.

Authors:  J M Luce; R C Ostenson; S C Springmeyer; L D Hudson
Journal:  Chest       Date:  1979-12       Impact factor: 9.410

5.  [Dermatomycosis in extensive burns].

Authors:  K Sandner; C Schönborn
Journal:  Dtsch Gesundheitsw       Date:  1973-01-03

6.  Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

Authors:  P E Verweij; A J Rijs; B E De Pauw; A M Horrevorts; J A Hoogkamp-Korstanje; J F Meis
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

7.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

8.  Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient.

Authors:  M J Stiller; L Teperman; S A Rosenthal; A Riordan; J Potter; J L Shupack; M A Gordon
Journal:  J Am Acad Dermatol       Date:  1994-08       Impact factor: 11.527

9.  MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.

Authors:  H J Schmitt; E M Bernard; J Andrade; F Edwards; B Schmitt; D Armstrong
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

10.  Disseminated Aspergillus ustus infection following cardiac surgery.

Authors:  L M Weiss; W A Thiemke
Journal:  Am J Clin Pathol       Date:  1983-09       Impact factor: 2.493
View more
  33 in total

1.  In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.

Authors:  C B Moore; C M Walls; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.

Authors:  A Espinel-Ingroff; M Bartlett; V Chaturvedi; M Ghannoum; K C Hazen; M A Pfaller; M Rinaldi; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 3.  Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Authors:  Juliette Pavie; Claire Lacroix; Dea Garcia Hermoso; Marie Robin; Christèle Ferry; Anne Bergeron; Martine Feuilhade; Françoise Dromer; Eliane Gluckman; Jean-Michel Molina; Patricia Ribaud
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp.

Authors:  Virginie Planche; Sebastien Ducroz; Alexandre Alanio; Marie-Elisabeth Bougnoux; Olivier Lortholary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

5.  Invasive Aspergillosis of the Hand Caused by Aspergillus ustus: a Case Report.

Authors:  Olushola Olorunnipa; Andrew Y Zhang; Catherine M Curtin
Journal:  Hand (N Y)       Date:  2009-06-30

6.  Cerebral aspergillosis caused by Aspergillus granulosus.

Authors:  Deanna A Sutton; Brian L Wickes; Anna M Romanelli; Michael G Rinaldi; Elizabeth H Thompson; Annette W Fothergill; Megan K Dishop; Okan Elidemir; George B Mallory; Siby P Moonnamakal; Adekunle M Adesina; Marc G Schecter
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole.

Authors:  A Espinel-Ingroff
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

8.  Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study.

Authors:  A Espinel-Ingroff; A Fothergill; J Peter; M G Rinaldi; T J Walsh
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

9.  Aspergillus calidoustus sp. nov., causative agent of human infections previously assigned to Aspergillus ustus.

Authors:  János Varga; Jos Houbraken; Henrich A L Van Der Lee; Paul E Verweij; Robert A Samson
Journal:  Eukaryot Cell       Date:  2008-02-15

10.  Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method.

Authors:  A Espinel-Ingroff; A Chowdhary; G M Gonzalez; C Lass-Flörl; E Martin-Mazuelos; J Meis; T Peláez; M A Pfaller; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.